Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 25, 2015 16:10 ET | Source: Keryx Biopharmaceuticals, Inc.

Keryx Biopharmaceuticals Announces Participation at Upcoming Investor Conferences

NEW YORK, Feb. 25, 2015 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) today announced that corporate presentations will be delivered at the following upcoming investor...
February 18, 2015 08:00 ET | Source: Keryx Biopharmaceuticals, Inc.

Keryx Biopharmaceuticals, Inc. to Host Conference Call on Fourth Quarter and Year End 2014 Financial Results

NEW YORK, Feb. 18, 2015 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), a biopharmaceutical company focused on bringing innovative therapies to market for patients with renal...
January 21, 2015 19:53 ET | Source: Keryx Biopharmaceuticals, Inc.

Keryx Biopharmaceuticals, Inc. Announces Pricing of $110 Million Public Offering of Common Stock

NEW YORK, Jan. 21, 2015 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) today announced the pricing of an underwritten public offering of common stock consisting of 9,166,667 shares...
January 20, 2015 16:05 ET | Source: Keryx Biopharmaceuticals, Inc.

Keryx Biopharmaceuticals, Inc. Announces $100 Million Proposed Public Offering of Common Stock

NEW YORK, Jan. 20, 2015 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) today announced that it has commenced a $100 million underwritten public offering of shares of its common...
January 11, 2015 22:00 ET | Source: Keryx Biopharmaceuticals, Inc.

Keryx Biopharmaceuticals Announces Transition of Leadership

NEW YORK and BOSTON, Jan. 11, 2015 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) (the "Company") today announced it will be transitioning the role of Chief Executive Officer from...
January 07, 2015 07:30 ET | Source: Keryx Biopharmaceuticals, Inc.

Keryx Biopharmaceuticals to Present at the 33rd Annual J.P. Morgan Healthcare Conference

NEW YORK, Jan. 7, 2015 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) today announced that Ron Bentsur, the Company's Chief Executive Officer, will be presenting at the 33rd Annual...
December 22, 2014 07:30 ET | Source: Keryx Biopharmaceuticals, Inc.

Keryx Biopharmaceuticals Announces Commercial Launch of AURYXIA(TM) (ferric citrate) Tablets in the United States

NEW YORK, Dec. 22, 2014 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) (the "Company") today announced it has begun shipping AURYXIA™ (ferric citrate) tablets to wholesalers in...
December 08, 2014 07:30 ET | Source: Keryx Biopharmaceuticals, Inc.

Keryx Biopharmaceuticals, Inc. to Present at the Oppenheimer & Co. Inc. 25th Annual Healthcare Conference

NEW YORK, Dec. 8, 2014 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) today announced that Ron Bentsur, the Company's Chief Executive Officer, will present at the Oppenheimer &...
December 04, 2014 07:30 ET | Source: Keryx Biopharmaceuticals, Inc.

Keryx Biopharmaceuticals Announces Issuance of a New U.S. Patent for Auryxia(TM) (ferric citrate) Covering Orally Administrable Forms

NEW YORK, Dec. 4, 2014 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) announced today that the U.S. Patent and Trademark Office issued U.S. Patent No. 8,901,349 on December 2, 2014....
December 02, 2014 07:30 ET | Source: Keryx Biopharmaceuticals, Inc.

Auryxia(TM) (Ferric Citrate) Phase 2 Data Published in the American Journal of Kidney Disease

NEW YORK, Dec. 2, 2014 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), a biopharmaceutical company focused on bringing innovative therapies to market for patients with renal disease,...